News & Events

Find out the latest with BOPA, Oncology, and upcoming events

By BOPA Committee on 4th March 2022

Complimentary January 2022 JOPP issue for BOPA members

With the help of an educational grant from Novartis and in partnership with SAGE Publishing we are pleased to provide you with complimentary access to the January 2022 interactive issue…

Read article
By BOPA Committee on 4th March 2022

RSPH accredits “Let’s Communicate Cancer” e-learning programme from the British Oncology Pharmacy Association

The “Let’s Communicate Cancer” e-learning programme from the British Oncology Pharmacy Association (BOPA) has received accreditation from RSPH. RSPH | RSPH accredits “Let’s Communicate Cancer” e-learning programme from the British…

Read article
By BOPA Committee on 24th February 2022

CRUK Consent Forms – Acalabrutinib, Ibrutinib and Bendamustine-Rituximab

A new consent form for Acalabrutinib has been added for CLL. In addition,  Ibrutinib and Bendamustine-Rituximab consent forms have been updated. They are now available on the CRUK website at:…

Read article
By BOPA Committee on 18th February 2022

Guy’s Cancer Academy Online Post-graduate Module in Advanced Prostate Cancer

Guy’s Cancer Academy Online Post-graduate Module in Advanced Prostate Cancer Applications deadline: Monday 28th February Course start date: Monday 7th March Guy’s Cancer Academy are offering a new fully online…

Read article
By BOPA Committee on 17th February 2022

Clinical Pharmacy Congress 2022 – 13th & 14th May

The Clinical Pharmacy Congress is the largest gathering for the clinical pharmacy profession in the UK taking place this 13th-14th May 2022 at ExCeL London – please register with promo code BOPA.…

Read article
By BOPA Committee on 11th February 2022

Your Cancer treatment Record – CRUK

Message from CRUK: Within your teams please could ask patients to complete the survey – cruk.org/treatment-record-survey

Read article
By BOPA Committee on 8th February 2022

Setting Up a Cancer Centre: A WHO–IAEA Framework

Congratulations and a huge thank you to the following BOPA Members who have been involved in the publication of the below Book –   Author affiliations and contacts for pharmacy…

Read article
By BOPA E&T Sub-committee on 8th February 2022

SAVE THE DATE – BOPA Introduction to Oncology Course is BACK – 17th May 2022

17th May 2022 – The BOPA Introduction to Oncology Study Day is BACK for 2022. Subject to government restrictions, it will be held face-to-face on at The Conference Centre in…

Read article
By UK Chemo Board on 4th February 2022

PUBLISHED by UKCB: Standards for the safer use of ePMA systems for use in SACT Services

Please click here to see version 3.0 of the Standards for the safer use of ePMA systems for use in SACT Services. We would like to thank everyone involved in all…

Read article
By UK Chemo Board on 4th February 2022

PUBLISHED by UKCB: Position Statement on Hepatitis B Virus Screening and Reactivation Prophylaxis for Patients Planned to Receive Immunosuppressive SACT

Dear All,   Please click here to see the final version of the Position Statement on Hepatitis B Virus Screening and Reactivation Prophylaxis for Patients Planned to Receive Immunosuppressive SACT…

Read article
By UK Chemotherapy Board on 4th February 2022

PUBLISHED by UKCB: National SACT Protocols: Options Appraisal

For information – please click here to see the final version of the National SACT Protocols: Options Appraisal. https://www.ukchemotherapyboard.org/publications The UK Chemotherapy Board will discuss the next steps at our next meeting. Kind regards,…

Read article
By BOPA Committee on 4th February 2022

BOPA recommendations for the use of Tall Man lettering for SACT within the UK

Please click here to see the BOPA recommendations for the use of Tall Man lettering for SACT within the UK. Also available here: https://www.bopa.org.uk/resources/bopa-recommendations-of-the-use-of-tall-man-lettering-for-systemic-anti-cancer-treatments-sact-in-the-united-kingdom-v1-0/  Kind regards, The BOPA  Executive Committee 

Read article